LAUSANNE, Switzerland and WALTHAM, MA – May 10, 2023 – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Bethyl Laboratories, a Fortis Life Sciences company and provider of high-quality reagents and custom service...

New York, NY -- May 8, 2023 – Marsh, the world’s leading insurance broker and risk advisor and a business of Marsh McLennan, and Octaviant Financial, Inc.,  a recognized innovator in novel drug warranty and payment models, announced today a new specialized warranty program tha...

Dallas, Texas--(Newsfile Corp. – May 4, 2023) - Alliance Resource Partners, L.P. (NASDAQ: ARLP): Stonegate Capital Partners updates coverage on Alliance Resource Partners, L.P. To download the report, view the full announcement, including downloadable images, bios, and more cl...

BOSTON – Advisors Living, the residential sales platform of Boston Realty Advisors, the largest Boston-based independent commercial real estate and consulting firm, yesterday celebrated the Grand Opening of its new sales office in Merrimac, MA, an office ideally located to ser...

Cambridge, MA – May 2, 20223 -- hC Bioscience (Private) announced that Leslie Williams, president and CEO, will deliver a presentation on the science behind tRNA-based therapies and the company's therapeutic programs at the Locust Walk RNA Innovation Conference on Tuesday, May...

OTTAWA, Canada – May 2, 2023 – GaN Systems, the global leader in GaN (gallium nitride) power semiconductors, today announced that it will be exhibiting innovative GaN solutions and presenting “Efficiency and Profitability in the Data Center with GaN” at Data Center World, the ...

DALLAS, TX -- May 1st, 2023 --  Civeo Corporation (NYSE: CVEO): Stonegate Capital Partners initiates their coverage on Civeo Corporation. The full report can be accessed by clicking on the following link: Civeo Q1 2023 Report COMPANY UPDATES Significant Free Cash Flow Generat...

DALLAS, TX -- April 28th, 2023 -- Plumas Bancorp (Nasdaq: PLBC): Stonegate Capital Partners updates coverage on Plumas Bancorp (Nasdaq: PLBC). The full report can be accessed by clicking on the following link: Plumas Bancorp 2023 Q1 Report Company Summary Continued growth: As...

Encinitas, California, April 27, 2023 – Kiora Pharmaceuticals (NASDAQ: KPRX) presented preliminary results from an ongoing clinical trial showing its investigational drug, KIO-301, has the potential to restore light perception in patients who are blind or living with ultra-low...

DALLAS, TX -- April 27th, 2023 -- Plumas Bancorp (Nasdaq: PLBC): Stonegate Capital Partners updates coverage on Plumas Bancorp (Nasdaq: PLBC). The full report can be accessed by clicking on the following link: Plumas Bancorp 2023 Q1 Report Company Summary Continued growth: A...